Journal of Cancer Cervix Eradication
Journal of Cancer Cervix Eradication
Volume :2 - Issue :1
Clinico-cytological pattern of Pap smears in S.C.B.Medical College, Cuttack in 2016
Debasmita Das1 , Asaranti Kar,Shreya Rath1
2018; Volume: 2 Issue: 1 Pages: 1-4
JCCE:08
Small Cell Carcinoma of the Cervix: A Rare Entity
Lucy Pattnayak*
2018; Volume: 2 Issue: 1 Pages: 5-9
JCCE:09
Clinico-cytological Pattern of Papsmeer at AHRCC in 2016
Sudiptee Das 1 , Itishree Das,Sashibhusan Dash3 , Bagmi Mishra3 , Subhransu Kumar Hota3 . Arpita Pandia3 , Kusumbati Besra ,Sasmita Panda 3 , Sagarika Samantaray
2018; Volume: 2 Issue: 1 Pages: 10-15
JCCE:10
Human Papilloma Virus Vaccines
Pragyan Paramita Giri
2018; Volume: 2 Issue: 1 Pages: 16-19
JCCE:11
Cell blocks diagnosis of carcinoma in cancer cervix-a case report
Sashibhusan Dash, Debasish Kar, S. Pattanaik, O.P Agarwal , C. Meher, Lucy Pattanyak
2018; Volume: 2 Issue: 1 Pages: 20-21
JCCE:12
Journal of Cancer Cervix Eradication
Vol:2: Issue-1
Clinico-cytological pattern of Pap smears in S.C.B.Medical College, Cuttack in 2016
Debasmita Das1, Asaranti Kar,Shreya Rath1
Journal of Cancer Cervix Eradication (2018)1, 1-4
JCCE:06
Debasmita Das1, Asaranti Kar,Shreya Rath1“Clinico-cytological pattern of Pap smears in S.C.B.Medical College, Cuttack in 2016“, Journal of Cancer Cervix Eradication (2018)1, 1-4
Background: Cervical cancer screening by pap smear is one of the most important tools for its diagnosis in the early stage. This study attempts to explore various lesions of uterine cervix [inflammatory lesions and growths], to find out target age groups in which screening efforts can be concentrated for early detection. This study was carried out with an objective to evaluate all previously conducted cervical smears examined at a teaching tertiary hospital during a period of one-year. Methods: Detailed clinical data and Pap smears were obtained and all the smears were reported as per the 2001 Bethesda system by cytopathologists. Then the data were noted in a structured proforma and evaluated. Results: 3414 Pap smears were examined during the period from January 2016 till December, 2016. Maximum numbers of patients were – 40 years (fourth decade) but malignancies were common in females after 50 years. A total of 3104 smears were reported as Negative for Intraepithelial Lesion or Malignancy (NILM), of which 2851 were inflammatory smears with reactive cellular changes.78 cases were reported to have epithelial cell abnormalities. Conclusion: Though cervical cancer screening can be done by cervical cytology known as the Pap test or Pap smear, and many other methods including HPV DNA testing, Pap test is easy, rapid, cost effective and more specific (more than 90%).It detects abnormal cells in early stage which later may develop into malignant cells. It can help in decrease in incidence of cancer cervix along with its downstaging.
©2018 The Authors. Production and hosting by Newredmars Education.
Small Cell Carcinoma of the Cervix: A Rare Entity
Lucy Pattnayak*
Journal of Cancer Cervix Eradication (2018) 2, 5-9
JCCE:07
Lucy Pattnayak*, “Small Cell Carcinoma of the Cervix: A Rare Entity”,Journal of Cancer Cervix Eradication (2018) 2, 5-9
Abstract: Small cell carcinoma of the cervix is a rare entity and diagnosis needs proper pathological investigations. Besides histopathology, immunohistochemistry should be done to rule out other small round blue cell tumors. immunohistochemistry, they are immunoreactive for cytokeratin, epithelial membrane antigen, carcino embryonic antigen, NSE, Leu 7, synaptophysin and chromogranin. Several combination chemotherapy regimens have been demonstrated to achieve better survival for patients primarily treated with surgery for small cell carcinoma of the uterine cervix. A rae case of advanced stage small cell carcinoma of the uterine cervix is reported which was successfully treated with neoadjuvant chemotherapy followed by chemoradiation.
©2018 Newredmars Education . All rights reserved.
Clinico-cytological Pattern of Papsmeer at AHRCC in 2016
Sudiptee Das 1, Itishree Das,Sashibhusan Dash3, Bagmi Mishra3, Subhransu Kumar Hota3 . Arpita Pandia3,Kusumbati Besra,Sasmita Panda 3, Sagarika Samantaray,
Journal of Cancer Cervix Eradication (2018) 2, 10-15
JCCE:08
Sudiptee Das 1, Itishree Das,Sashibhusan Dash3, Bagmi Mishra3, Subhransu Kumar Hota3 . Arpita Pandia3,Kusumbati Besra,Sasmita Panda 3, Sagarika Samantaray,Clinico-cytological Pattern of Papsmeer at AHRCC in 2016 Journal of Cancer Cervix Eradication (2018) 2, 10-15
Abstract: Background: Cancer cervix is the second most common cancer among women in India one of the leading causes of deaths. Pap smear screening is an essential part of a woman’s routine health care. It is a useful screening test to detect abnormal cells, including precancerous lesions, as well as malignant cancer cells. Aims and Objective: Our aimed to study the role of conventional cytology (Pap smear) in early diagnosis of cancerous /precancerous lesion of cervix. Materials and Methods: This retrospective study was con Pathology, A.H.Regional Cancer Centre, and Cuttack for duration of one year from January 2016 to December 2016.During this study period, received cervical smears from Gynecology Department were stained by Pap protocol and subseq cytopathologist and reported according to Bethesda 2014. Result: A total 1198 pap smears studied over a period of one year duration. The age of the patients undergoing PAP smear test ranged from 21 to 85 yrs with the mean age of 52.5years.Out of total cases, on cytological evaluation, 568 (47.41%)cases were diagnosed from malignant and 548(45.47%) cases were diagnosed from benign. HSIL/LSIL cases and radiation changes were observed in 26 (2.17%)and in 10(0.83%) cases respectively.46 (3.83%)were microscopically looking suspicious. Among malignant lesion squamous cell carcinoma was the maximum, 554 (97.53%) followed by 14 (2.46%) adenocarcinoma.The incidence of carcinoma was highest in patients in whom carcinoma was suspected clinically. Conclusion: Pap test is an useful tool for screening of cancer cervix to reduce morbidity and mortality in females. 2018 The Authors. Published by Newredmars Education.
Human Papilloma Virus Vaccines
Pragyan Paramita Giri
Journal of Cancer Cervix Eradication (2018) 2, 16-19
JCCE:09
Pragyan Paramita Giri, “Human Papilloma Virus Vaccines”, Journal of Cancer Cervix Eradication (2018) 2, 16-19
Abstract : Human papilloma Virus (HPV) is a member of the family Papillomaviridae.(1) They are small, non-enveloped deoxyribonucleic acid (DNA) viruses.(2) They are classified according to DNA sequence using the L1 open reading frame of the genome. HPVs more than 200 related viruses. HPV infections produce epithelial lesions of the skin and mucous membranes. Although most infections are benign and self-limited, persistent infections by a set of the more than 150 genotypes can lead to a variety of epithelial malignancies. association with cervical cancer, HPVs are further grouped into high types, probable high-risk types and low-risk types. (Munoz et al., 2003) Worldwide, high-risk type HPV-16 and 18 contribute over 70% cervical cancer cases (the most prevalent being HPV 60% and HPV-18 in at least 10–12%). Vaccine against high risk HPV types 6, 11,16, 18 are given to prevent HPV infection. Recently, HPV vaccines against nine high risk subtypes 6, 11,16,18,31,33,45,52 and 58
are available.
©2018 Newredmars Education. All rights reserved.
Cell blocks diagnosis of carcinoma in cancer cervix-a case report
Sashibhusan Dash, Debasish Kar, S. Pattanaik, O.P Agarwal , C. Meher, Lucy Pattanyak
Journal of Cancer Cervix Eradication (2018) 2, 20-21
JCCE:10
Sashibhusan Dash, Debasish Kar, S. Pattanaik, O.P Agarwal , C. Meher, Lucy Pattanyak,”Cell blocks diagnosisof carcinoma in cancer cervix-a case report”,Journal of Cancer Cervix Eradication.(2018) 2, 20-21
Abstract: Carcinoma cervix is the commonest cancer responsible for about 5% of all cancer deaths in women worldwide. A 36 year old female patent was diagnosed as carcinoma cervix stage III B . With an aim to give radiotherapy while doing routine USG of abdomen and pelvis metastatic deposit were seen in the liver. Cytosmear shows the features of metastatic carcinoma where as the cell block reported as metastatic squamous cell carcinoma of liver. A chemotherapy protocol of paclitaxel and carboplatin was administered. Complete work up of a case is mandatory before treatment. In a case of cancer cervix in advanced stage with metastasis in liver the cell block diagnosis is an adjunct to cytosmear to reach a final diagnosis.